These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16688431)

  • 21. HIV drugs. New Congress could create hurdles for drug patents.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17319014
    [No Abstract]   [Full Text] [Related]  

  • 22. Issue one: health care.
    Thomas R
    Newsweek; 1992 Dec; 120(26):32. PubMed ID: 10123231
    [No Abstract]   [Full Text] [Related]  

  • 23. Health policy versus industrial policy in the pharmaceutical sector: the case of Canada.
    Vandergrift M; Kanavos P
    Health Policy; 1997 Sep; 41(3):241-60. PubMed ID: 10170092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation.
    Chimonas S; Rothman DJ
    Health Aff (Millwood); 2005; 24(4):949-60. PubMed ID: 16136634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
    Doran E; Alexander Henry D
    J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract]   [Full Text] [Related]  

  • 27. A hamstrung healthcare agenda. Dems limited by fiscal, political constraints, but there are a few opportunities.
    Sloane T
    Mod Healthc; 2007 Jan; 37(2):20. PubMed ID: 17243340
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceuticals and the consumer movement: the ambivalences of 'patient power'.
    Lofgren H
    Aust Health Rev; 2004 Nov; 28(2):228-37. PubMed ID: 15527403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What might the 110th Congress have in store for home health and hospice care in 2007-2008?
    Markey C
    Home Healthc Nurse; 2007 May; 25(5):343-4. PubMed ID: 17495567
    [No Abstract]   [Full Text] [Related]  

  • 30. Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases.
    Sonderholm J
    J Med Ethics; 2009 May; 35(5):315-9. PubMed ID: 19407038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry'. Too much too late?
    Kerwin R
    J Psychopharmacol; 2007 Mar; 21(2):131-3. PubMed ID: 17329287
    [No Abstract]   [Full Text] [Related]  

  • 32. Putting off the tough choices. As a long-term fiscal crisis worsens, Washington dithers.
    Sloane T
    Mod Healthc; 2007 Feb; 37(7):18. PubMed ID: 17432255
    [No Abstract]   [Full Text] [Related]  

  • 33. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 34. Biotech as Bush bows out.
    Lorenzo A
    Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
    [No Abstract]   [Full Text] [Related]  

  • 35. Are patent expirations the answer to improving patient adherence?
    Klepser DG
    Am J Manag Care; 2008 Dec; 14(12):787-8. PubMed ID: 19067495
    [No Abstract]   [Full Text] [Related]  

  • 36. European Commission's proposals on trade secrets.
    McKee M; Labonté R
    BMJ; 2015 Mar; 350():h1369. PubMed ID: 25762539
    [No Abstract]   [Full Text] [Related]  

  • 37. Collateral damages.
    Bradley-Springer L
    J Assoc Nurses AIDS Care; 2008; 19(2):87-9. PubMed ID: 18328958
    [No Abstract]   [Full Text] [Related]  

  • 38. A day late and a few million dollars short.
    Goldenson D
    Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reforming patient assistance programs: perfect world meets real world.
    Weinberg M
    Health Aff (Millwood); 2009; 28(3):839-42. PubMed ID: 19414895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.